Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Change in Intangibles (2016 - 2020)

Niagen Bioscience (NAGE) has disclosed Change in Intangibles for 8 consecutive years, with $18000.0 as the latest value for Q3 2020.

  • On a quarterly basis, Change in Intangibles changed N/A to $18000.0 in Q3 2020 year-over-year; TTM through Dec 2021 was $18000.0, a 0.0% change, with the full-year FY2020 number at $18000.0, up 80.0% from a year prior.
  • Change in Intangibles was $18000.0 for Q3 2020 at Niagen Bioscience, up from $10000.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $184000.0 in Q2 2017 to a low of $10000.0 in Q4 2016.
  • A 5-year average of $59550.0 and a median of $25250.0 in 2016 define the central range for Change in Intangibles.
  • Peak YoY movement for Change in Intangibles: tumbled 53.85% in 2016, then skyrocketed 1126.67% in 2017.
  • Niagen Bioscience's Change in Intangibles stood at $15000.0 in 2016, then surged by 1126.67% to $184000.0 in 2017, then tumbled by 53.26% to $86000.0 in 2018, then crashed by 88.37% to $10000.0 in 2019, then soared by 80.0% to $18000.0 in 2020.
  • Per Business Quant, the three most recent readings for NAGE's Change in Intangibles are $18000.0 (Q3 2020), $10000.0 (Q1 2019), and $86000.0 (Q4 2018).